Abstract
Background
Desirability of outcome ranking (DOOR) is an innovative approach in clinical trials to evaluate the global benefits and risks of an intervention. We developed and validated a DOOR endpoint for Staphylococcus aureus bloodstream infection (BSI) through a survey to infectious diseases clinicians and secondary analysis of trial data.
Methods
We administered a survey of 20 cases of S. aureus BSI, asking respondents to rank outcomes by global desirability. Correlations and percentage of pairwise agreement among rankings were estimated to inform development of a DOOR endpoint, which was applied to 2 prior S. aureus BSI trials. The probability that a patient randomly assigned to experimental treatment would have a better DOOR ranking than if assigned to control was estimated. Results were also analyzed using partial credit, which is analogous to scoring an academic test, assigning 100% to the most desirable outcome, 0% to the least, and “partial credit” to intermediate ranks.
Results
Forty-two recipients (97%) completed the survey. The DOOR endpoint fitting these rankings (r = 0.89; 95% confidence interval, 0.67 to 0.94) incorporated survival plus cumulative occurrence of adverse events, cure, infectious complications, and ongoing symptoms. Tailored versions of this endpoint were applied to 2 S. aureus BSI trials, and both demonstrated no benefit of the experimental treatment using DOOR and partial credit analysis.
Conclusions
Using S. aureus BSI as an exemplar, we developed a DOOR endpoint that can be used as a template for development of DOOR endpoints for other diseases. Future trials can incorporate DOOR to allow for global assessment of patient experience.
Desirability of outcome ranking (DOOR) evaluates the global benefits and risks of an intervention and provides pragmatic information for medical decision-making. From a survey of infectious diseases experts, a DOOR endpoint for Staphylococcus aureus bloodstream infection was developed and applied to 2 prior trials.
Reference Type
Journal Article
Periodical Full
Clinical infectious diseases
Publication Year
2019
Publication Date
May 2,
Volume
68
Issue
10
Start Page
1691
Other Pages
1698
Publisher
Oxford University Press
Place of Publication
US
ISSN/ISBN
1058-4838
Document Object Index
10.1093/cid/ciy766
URL
https://www.ncbi.nlm.nih.gov/pubmed/30321315
PMID
30321315